Rapid Dose Therapeutics Corp. (CSE:DOSE)

Market Cap	19.60M -41.3%
Revenue (ttm)	2.78M +72.8%
Net Income	-4.37M
EPS	-0.03
Shares Out	135.18M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	60,982
Average Volume	48,307
Open	0.1450
Previous Close	0.1400
Day's Range	0.1350 - 0.1450
52-Week Range	0.1250 - 0.2400
Beta	-0.90
RSI	50.39
Earnings Date	Jan 29, 2026

About Rapid Dose Therapeutics

Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release into the blood stream a list of pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip Energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system, as well as dental products. It also engages in the research, production, provis...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Mark Upsdell
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: DOSE

Financial Performance

In fiscal year 2025, Rapid Dose Therapeutics's revenue was 2.09 million, an increase of 104.34% compared to the previous year's 1.02 million. Losses were -5.40 million, 25.5% more than in 2024.